Breast cancer is the leading cause of cancer-related death in women worldwide and the fifth most common cause of cancer death overall. Most women with breast cancer have a good prognosis if the cancer is detected at an early stage and the patients have access to the appropriate treatment and disease management. This study aims to evaluate the impact of pharmacist-led interventions on breast cancer management and health outcomes. A literature review was carried out through the scientific databases PubMed, Scopus, and Web of Science using predefined keywords. Only full-text original articles written in English that investigated the role of the pharmacist in the management of breast cancer were included in the final analysis. No publication date limits were set. A total of 1625 articles were retrieved from the electronic databases, of which 14 met the inclusion criteria. The current scoping review consists of different study types, including randomized controlled trials, cross-sectional studies, pre-post studies, retrospective cohort studies, quality improvement projects, case-control studies, and one pharmacoeconomic study. Pharmacists commonly provided the following interventions: consultations regarding chemotherapy treatment, risk assessment and patient education, adverse drug reactions and drug-drug interactions detection, and adherence assessment. This scoping review highlights the beneficial effects of the involvement of pharmacists in breast cancer management, such as better quality of life, reduced drug interaction risk, greater adherence rates, and improved patient knowledge. This confirms the importance of including the pharmacist in the oncology team caring for patients with breast cancer.

Since ancient times, essential oils (EOs) have been used, thoroughly explored, and regarded as products of great importance for humanity. Currently, EOs represent not only an important part of the contemporary pharmaceutical and cosmetic industry but are also considered as sources for novel drug candidates. The article discusses the applications of EOs in historical terms, the current applications, and the future perspectives. Although there are many studies that involve EOs, the therapeutic potential of EOs is not fully investigated. In the next decades it is highly likely that some compounds, isolated from EOs, could be included in the composition of novel drug candidates with targets in neurology, cardiology, or oncology. Moreover, EOs represent important key points in the development of novel environmentally friendly preservatives and pesticides.

The current trend in consumers’ preferences for healthy lifestyles resulted in an increased demand for natural products. Many companies replaced synthetic compounds, used as preservatives, flavourings, or active ingredients, with natural ones. Nowadays, essential oils (EOs) and compounds isolated from EOs are regarded as promising and safe alternatives for many synthetic substances used as food additives, food preservatives, repellents, antimicrobial agents, etc. A great dynamic regarding the studies on EOs and in the global market of EOs was also reported. Moreover, the European market of EOs represents a significant share of the global EOs market. According to some recent reports, the European EOs market generated a revenue of more than 11 billion USD per year recently and is expected to reach well over 20 billion USD per year in 2030. The article provides an overview concerning EOs regulation in the European Union (EU). In the EU, the different product categories containing EOs are controlled under specific regulations to enhance product quality and safety. The manuscript highlights the key points of the EU legislation on EOs intended for food purposes, cosmetics, and health care.

Inappropriate polypharmacy is a common occurrence in elderly patients, resulting in increased adverse drug reactions, nonadherence, and increased healthcare costs. Medication review and deprescribing are the primary strategies described in the literature for dealing with problematic polypharmacy. To effectively carry out the medication review, various tools have been developed. These tools can support medication review in a variety of ways. Some tools include a list of medications requiring detailed attention, while others guide medical professionals with principles and algorithms for reviewing and prescribing medicines. A third category of tools focuses on tracking and identifying symptoms that may be due to drug-related problems. This article aims to present the medication review support tools used in the management of polypharmacy in the geriatric population, emphasizing their advantages and disadvantages.

Food supplements (FSs) are widely used by the general population and are commonly available in community pharmacies. As highly accessible healthcare professionals, pharmacists are well positioned to provide evidence-based information and guidance regarding their safe and appropriate use. Adequate knowledge of FSs is essential for pharmacists to prevent adverse effects, identify potential interactions with other medications, and ensure rational use. The objective of this study was to assess community pharmacists’ knowledge regarding FSs and their attitudes towards dispensing and patient counseling practices. A literature review was carried out using the scientific databases PubMed, Scopus, and Web of Science. The following keywords were used: (“food supplements” OR “dietary supplements”) AND (“pharmacists’ knowledge”) AND (“pharmacists’ attitudes”). A total of 789 articles were identified from the electronic databases, of which 31 met the inclusion criteria. The majority of studies were conducted in Asia, with fewer in Europe, North America, and Australia. Cross-sectional survey-based studies represented the predominant research design. The analyzed studies showed that community pharmacists generally demonstrate insufficient knowledge regarding FSs. Nonetheless, they tend to hold a positive attitude toward the use of FSs and recognize their responsibility to counsel patients on safe consumption. Several barriers affecting pharmacists’ ability to deliver evidence-based guidance were identified, including limited training, lack of basic nutrition education, and insufficient access to reliable information sources. The findings indicate the need for targeted strategies to enhance pharmacists’ competencies and improve the quality of patient counseling in this domain.